PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 123 filers reported holding PROVENTION BIO INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $582,979 | -70.7% | 24,190 | -87.2% | 0.00% | -60.0% |
| Q4 2022 | $1,990,775 | +205.8% | 188,342 | +30.2% | 0.01% | +400.0% |
| Q3 2022 | $651,000 | +118.5% | 144,683 | +94.0% | 0.00% | – |
| Q2 2022 | $298,000 | -19.0% | 74,581 | +13.9% | 0.00% | – |
| Q4 2021 | $368,000 | -31.3% | 65,482 | -21.8% | 0.00% | -100.0% |
| Q3 2021 | $536,000 | -59.8% | 83,697 | -47.1% | 0.00% | -50.0% |
| Q2 2021 | $1,334,000 | +46.6% | 158,253 | +194.5% | 0.00% | 0.0% |
| Q4 2020 | $910,000 | +0.9% | 53,742 | -23.5% | 0.00% | -33.3% |
| Q3 2020 | $902,000 | -7.5% | 70,275 | +1.7% | 0.00% | -40.0% |
| Q2 2020 | $975,000 | +140.1% | 69,076 | +56.5% | 0.01% | +66.7% |
| Q1 2020 | $406,000 | +294.2% | 44,126 | +536.4% | 0.00% | +200.0% |
| Q4 2019 | $103,000 | +281.5% | 6,934 | +76.6% | 0.00% | – |
| Q3 2019 | $27,000 | – | 3,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 6,000,000 | $43,920,000 | 2.10% |
| VR Adviser, LLC | 1,118,653 | $8,189,000 | 1.33% |
| DG Capital Management, LLC | 522,568 | $3,825,000 | 0.77% |
| Atom Investors LP | 42,680 | $312,000 | 0.15% |
| ADVISORY RESEARCH INC | 235,000 | $1,720,000 | 0.14% |
| Perceptive Advisors | 791,549 | $5,794,000 | 0.12% |
| Verition Fund Management LLC | 1,086,593 | $7,954,000 | 0.10% |
| Virtus ETF Advisers LLC | 26,467 | $194,000 | 0.09% |
| 1900 WEALTH MANAGEMENT LLC | 95,555 | $699,000 | 0.07% |
| RICE HALL JAMES & ASSOCIATES, LLC | 220,065 | $1,611,000 | 0.06% |